Stem cell-derived exosomes repair ischemic muscle injury by inhibiting the tumor suppressor Rb1-mediated NLRP3 inflammasome pathway
Main Authors: | Yanli Wang, Wenping Xie, Bin Liu, Hui Huang, Wei Luo, Yu Zhang, Xiangbin Pan, Xi-Yong Yu, Zhenya Shen, Yangxin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00520-8 |
Similar Items
-
Inflammasomes as therapeutic targets in human diseases
by: Yangxin Li, et al.
Published: (2021-07-01) -
NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes
by: Pu Hong, et al.
Published: (2019-06-01) -
Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
by: Ya-Shuo Feng, et al.
Published: (2020-06-01) -
NLRP3 Inflammasome and Inflammatory Bowel Disease
by: Yu Zhen, et al.
Published: (2019-02-01) -
Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)